Anna Vildhede

1.2k total citations
23 papers, 979 citations indexed

About

Anna Vildhede is a scholar working on Oncology, Pharmacology and Epidemiology. According to data from OpenAlex, Anna Vildhede has authored 23 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Pharmacology and 8 papers in Epidemiology. Recurrent topics in Anna Vildhede's work include Drug Transport and Resistance Mechanisms (17 papers), Liver Disease Diagnosis and Treatment (8 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Anna Vildhede is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Liver Disease Diagnosis and Treatment (8 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Anna Vildhede collaborates with scholars based in United States, Sweden and Germany. Anna Vildhede's co-authors include Per Artursson, Jacek R. Wiśniewski, Maria Karlgren, Agneta Norén, Emi Kimoto, Yurong Lai, U Haglund, Ulf Norinder, Manthena V. S. Varma and A. David Rodrigues and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Cellular Physiology.

In The Last Decade

Anna Vildhede

21 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Vildhede United States	13	583	349	251	203	181	23	979
Maria Karlgren Sweden	19	740 1.3×	567 1.6×	299 1.2×	438 2.2×	126 0.7×	31	1.4k
Mingxiang Liao United States	19	715 1.2×	533 1.5×	315 1.3×	309 1.5×	172 1.0×	46	1.2k
Mitchell E. Taub United States	19	908 1.6×	390 1.1×	464 1.8×	354 1.7×	109 0.6×	51	1.4k
Yannick Parmentier France	18	583 1.0×	335 1.0×	259 1.0×	265 1.3×	97 0.5×	38	1.1k
Agneta Norén Sweden	13	433 0.7×	229 0.7×	132 0.5×	158 0.8×	127 0.7×	20	832
Simone H. Stahl United Kingdom	17	527 0.9×	491 1.4×	212 0.8×	213 1.0×	118 0.7×	26	1.0k
Markus Keiser Germany	21	626 1.1×	194 0.6×	304 1.2×	185 0.9×	252 1.4×	36	1.3k
Robert Elsby United Kingdom	20	729 1.3×	551 1.6×	363 1.4×	367 1.8×	109 0.6×	25	1.6k
Kathleen M. Hillgren United States	18	823 1.4×	327 0.9×	424 1.7×	372 1.8×	76 0.4×	30	1.4k
David B. Duignan United States	17	514 0.9×	478 1.4×	197 0.8×	278 1.4×	54 0.3×	25	1.1k

Countries citing papers authored by Anna Vildhede

Since Specialization

Citations

This map shows the geographic impact of Anna Vildhede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vildhede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vildhede more than expected).

Fields of papers citing papers by Anna Vildhede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Vildhede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vildhede. The network helps show where Anna Vildhede may publish in the future.

Co-authorship network of co-authors of Anna Vildhede

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Vildhede. A scholar is included among the top collaborators of Anna Vildhede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Vildhede. Anna Vildhede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vildhede, Anna, Pär Nordell, Christine Ahlström, et al.. (2024). Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT Pharmacometrics & Systems Pharmacology. 13(6). 1029–1043. 4 indexed citations

Huang, Yingbo, Weifeng Tang, Anna Lundahl, et al.. (2023). Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling. Clinical Pharmacology & Therapeutics. 114(4). 825–835. 9 indexed citations

Lundahl, Anna, et al.. (2022). Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction. CPT Pharmacometrics & Systems Pharmacology. 11(9). 1194–1209. 12 indexed citations

Vildhede, Anna, Tommy B. Andersson, Fredrik Erlandsson, et al.. (2021). In Vitro Assessment of the Drug–Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters. Journal of Pharmacology and Experimental Therapeutics. 378(2). 108–123. 3 indexed citations

Ölander, Magnus, Christine Wegler, Jenny M. Pedersen, et al.. (2021). Hepatocyte size fractionation allows dissection of human liver zonation. Journal of Cellular Physiology. 236(8). 5885–5894. 18 indexed citations

Kanebratt, Kajsa P., Annika Janefeldt, Anna Vildhede, et al.. (2020). Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies. Journal of Pharmaceutical Sciences. 110(1). 422–431. 54 indexed citations

Vildhede, Anna, Emi Kimoto, Ryan M. Pelis, A. David Rodrigues, & Manthena V. S. Varma. (2019). Quantitative Proteomics and Mechanistic Modeling of Transporter‐Mediated Disposition in Nonalcoholic Fatty Liver Disease. Clinical Pharmacology & Therapeutics. 107(5). 1128–1137. 56 indexed citations

Li, Hui, Anika L. Dzierlenga, John Clarke, et al.. (2018). Gene-by-Environment Interaction of Bcrp−/− and Methionine- and Choline-Deficient Diet–Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition. Drug Metabolism and Disposition. 46(11). 1478–1486. 7 indexed citations

Bi, Yi‐An, Sumathy Mathialagan, Laurie Tylaska, et al.. (2018). Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug. Journal of Pharmacology and Experimental Therapeutics. 364(3). 390–398. 32 indexed citations

10.

Vildhede, Anna, Emi Kimoto, A. David Rodrigues, & Manthena V. S. Varma. (2018). Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes. Molecular Pharmaceutics. 15(8). 3227–3235. 21 indexed citations

11.

Vildhede, Anna, Chuong Nguyen, Brian K. Erickson, et al.. (2018). Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation. Drug Metabolism and Disposition. 46(5). 692–696. 26 indexed citations

12.

Li, Rui, Yi‐An Bi, Anna Vildhede, et al.. (2017). Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites. Drug Metabolism and Disposition. 45(7). 737–747. 10 indexed citations

13.

Bi, Yi‐An, Renato J. Scialis, Sarah Lazzaro, et al.. (2017). Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. The AAPS Journal. 19(3). 787–796. 39 indexed citations

14.

Mathialagan, Sumathy, Chester Costales, Laurie Tylaska, et al.. (2017). In vitrostudies with two human organic anion transporters: OAT2 and OAT7. Xenobiotica. 48(10). 1037–1049. 20 indexed citations

15.

Vildhede, Anna, André Mateus, Yurong Lai, et al.. (2016). Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach. Drug Metabolism and Disposition. 44(4). 505–516. 45 indexed citations

16.

Wiśniewski, Jacek R., Anna Vildhede, Agneta Norén, & Per Artursson. (2016). In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. Journal of Proteomics. 136. 234–247. 142 indexed citations

17.

Vildhede, Anna, Jacek R. Wiśniewski, Agneta Norén, Maria Karlgren, & Per Artursson. (2015). Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure. Journal of Proteome Research. 14(8). 3305–3314. 93 indexed citations

18.

Vildhede, Anna, Jacek R. Wiśniewski, Agneta Norén, Maria Karlgren, & Per Artursson. (2015). Comparative proteomics of human liver tissue and hepatocytes reveal systematic differences in proteins determining hepatic drug exposure.

19.

Vildhede, Anna, Maria Karlgren, Jacek R. Wiśniewski, et al.. (2014). Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions. Drug Metabolism and Disposition. 42(7). 1210–1218. 97 indexed citations

20.

Karlgren, Maria, Anna Vildhede, Ulf Norinder, et al.. (2012). Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions. Journal of Medicinal Chemistry. 55(10). 4740–4763. 287 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact